Are VC’s Bypassing Early Stage Health Deals?

Healthcare startups,Venture Capital,startups,funding,seed round,series a

(image: policymed.com)

Success stories, like the one of Memphis’ medical device accelerator Zeroto510, where 80% of their first class received follow on funding, seem to be growing scarce on a national scale.  In their first class of six startups at the ZeroTo510 program 5 of the startups received follow on funding, with one, Restore Medical Solutions, going straight to a $2.5 million dollar series A round.

Well national medical startup publication MedCity News, released two graphs this morning that may be alarming to early stage medical startups, who often need a lot more seed money than your social, mobile, webtech startups.

The data, published by CB Insights, shows a significant number of VCs are skipping over  earlier stage “seed round” deals for healthcare startups. Conversely, the same data set shows that the “series A crunch” may not be as prevalent in healthcare startups.

As you can see clearly from the data set Series A and Series B seem to be the preferred stage for a VC firm to get into a startup business, at least over the last five quarters.

According to MedCity News VC Funding in healtcare was up over the last year, in fact reaching  a “multi year high”. Also worthy to note is that the medical device category is eating up the most VC funds. That should be good for the next round of ZeroTo510, Rock Health and Health Box.

Restore Medical talks to us about their $2.5 million dollar Series A round. 

750x100

You Might Also Like